52208-11-4

Basic information

• Product Name: 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl carbamimidothioate
• CAS NO: 52208-11-4
• Molecular Formula: C₁₁H₁₁N₃O₂S
• Molecular Weight: 249.2889
• Mol File: 52208-11-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 425.8°C at 760 mmHg
• Flash Point: 211.3°C
• Density: 1.5g/cm³
• Vapor Pressure: 1.86E-07mmHg at 25°C
• Refractive Index: 1.717
• CAS DataBase Reference: 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl carbamimidothioate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl carbamimidothioate(52208-11-4)
• EPA Substance Registry System: 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl carbamimidothioate(52208-11-4)

Safety Data

• Hazardous Substances Data: 52208-11-4(Hazardous Substances Data)

Usage

General Description

2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl carbamimidothioate is a chemical compound with the molecular formula C11H11N3O2S, which is also known as thionamidilic methyl ester. It is a carbamate derivative and a potent inhibitor of carboxypeptidase A. 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl carbamimidothioate has been studied for its potential pharmaceutical applications, particularly as an anti-cancer agent. Additionally, it has been found to exhibit anti-inflammatory and immunomodulatory properties. However, further research is needed to fully understand its biological activities and potential therapeutic uses.

Upstream product

• 574-98-1 2-(2-bromoethyl)isoindoline-1,3-dione 
• 17356-08-0 thiourea 

Relevant articles and documents

Convenient and environment-friendly synthesis of sulfonyl chlorides from S -alkylisothiourea salts via N-chlorosuccinimide chlorosulfonation

A convenient, practical, and environmentally friendly method for the synthesis of sulfonyl chlorides has been developed. Structurally diverse sulfonyl chlorides were synthesized in moderate to excellent yields from S-alkylisothiourea salts, which can be easily prepared from readily accessible alkyl halides or mesylates and inexpensive thiourea, via N-chlorosuccinimide chlorosulfonation. In large-scale syntheses, the byproduct succinimide from 'waste water' can be conveniently converted into the starting reagent N-chlorosuccinimide with sodium hypochlorite (bleach) to make the method sustainable. Georg Thieme Verlag Stuttgart, New York.

β-Cyclodextrin derivatives that inhibit anthrax lethal toxin

Recently, we demonstrated that simultaneous blocking of bacterial growth by antibiotics and inhibition of anthrax toxin action with antibodies against protective antigen were beneficial for the treatment of anthrax. The present study examined the hypothesis that blocking the pore formed by protective antigen can inhibit the action of anthrax toxin. The potential inhibitors were chosen by a structure-based design using β-cyclodextrin as the starting molecule. Several β-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin. Per-substituted aminoalkyl derivatives displayed inhibitory activity and were protective against anthrax lethal toxin action at low micromolar concentrations. These results provide the basis for a structure-based drug discovery program, with the goal of identifying new drug candidates for anthrax treatment.

Search for cyclodextrin-based inhibitors of anthrax toxins: Synthesis, structural features, and relative activities

Recently, using structure-inspired drug design, we demonstrated that aminoalkyl derivatives of β-cyclodextrin inhibited anthrax lethal toxin action by blocking the transmembrane pore formed by the protective antigen (PA) subunit of the toxin. In the prese